Skip to main content

BehaVR CEO weighs in on potential $140M development deal

The company, founded by former Humana exec Aaron Gani in 2016, just inked a deal to develop and commercialize prescription digital therapeutics for treatment of social anxiety, generalized anxiety and major depressive disorders.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.